Department of Academic Clinical Studies

The Department of Academic Clinical Studies (Czech abbreviation OAKS) was newly established in January 2020 in response to a growing need of professional support of non-commercial, so called academic clinical trials where IHBT acts as the contractor or the national coordinator for the Czech Republic. The department took over the administration of ongoing academic studies (three studies of modern products of targeted treatment of acute lymphoblastic leukemia). The first clinical trial accompanying the department throughout the implementation process, including the protocol finalization, the authorization by regulatory and ethical authorities, the initiation of the first center up to the inclusion of the first patient, was the Pona-CELL study. This clinical project emerged at the IHBT premises in close